Read More Pharma Industry News Glenmark Pharmaceuticals expands cardiometabolic portfolio with new Empagliflozin drug launch Glenmark Pharmaceuticals Ltd. has introduced Empagliflozin, a widely recognized SGLT2 inhibitor, in India under the brand name Glempa.… byPallavi MadhirajuMarch 12, 2025